2 terminated, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow Urigen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome URG101, Placebo, Lidocaine - Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Terminated | Urigen | 91 | 2015-09-01 | 2026-02-03 |
| Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis URG101, Placebo - Painful Bladder Syndrome, Interstitial Cystitis | Phase 2 | Terminated | Urigen | 28 | 2007-08-28 | 2024-08-23 |
| Study of U101 for Bladder Pain and/or Urgency Alkalinized Lidocaine-Heparin - Pelvic Pain, Interstitial Cystitis | Phase 2 | Completed | Urigen | 90 | 2006-01-01 | 2006-09-29 |
Cystitis, Interstitial (3) · Pain (1) · Pelvic Pain (1) · Urinary Bladder Diseases (1)
United States (3)
C. Lowell Parsons, MD (2) · Jeff Proctor, M.D. (1)